Dutch Life Sciences & Health Conference

December 14, 2011

Life sciences sector has confidence in the future in spite of ups and downs

December 21, 2011

Presentations available
From a couple of speakers, the presentation or abstract is online available.

December 14, 2011

 Muscabiotics and Prognostix win Venture Challenge Fall 2011
Winners split € 25,000 prize money to further develop promising ventures.

The Fall 2011 edition of the Venture Challenge took a surprising turn when two winners were announced yesterday during the Dutch Life Sciences & Health conference in Media Plaza, Utrecht.

November 2, 2011

Pitch at the Investors Forum
The Investors Forum is an exciting opportunity for those companies looking for equity capital and/or partnerships with companies and institutes across the life science value chain, from biotech, med tech and pharma companies to financiers and universities.

Oktober 26, 2011

Dr. R. (Rudi) Pauwels
Dr. R. (Rudi) Pauwels, CEO and co-founder of Biocartis, will give a plenary lecture about the developments in the markets for diagnostic products.

Oktober 19, 2011

Interview Pwc
Find out what Arwin van der Linden (Partner at PwC and Leader of the Dutch Pharmaceuticals and Life Sciences group ) en Peter Paul Hoek (Senior Manager at PwC in the Dutch Pharmaceuticals and Life Sciences group) of PwC their experiences are with the Dutch Life Sciences & Health Conference so far and the Investors Forum in particular.

September 7, 2011

NGI Venture Challenge
A ‘must-do’ opportunity for all life sciences entrepreneurs and the ideal way to receive coaching and advice on essential elements of setting up a business. In two 3-day workshops, the facilitators and other ‘competing’ teams will challenge you to focus our business idea to create optimal customer value, and you will learn to pitch our business case.

July 19, 2011

Workshop Biopharmaceuticals finalised
The programme committee is proud to announce that the programme of the workshop ‘Biopharmaceuticals’ has been finalised with the following speakers:

July 6, 2011

  
We are very proud to announce our first keynote speaker: Prof. Désiré Collen. Prof. Collen is currently CEO and Chairman of ThromboGenicsand Director of the Molecular Cardiovascular Medicine Group (comprising the Center for Molecular and Vascular Biology of the K.U. Leuven, and the Center for Transgene Technology and Gene Therapy of the Flanders Interuniversity Institute for Biotechnology) in Leuven, Belgium.

June 16, 2011
 
The Dutch government has listed Life Sciences as one of the ‘top sectors’ for specific actions, indicating Life Sciences as an important sector for the Dutch economy. The top team kicked off its series of meetings within the country with a meeting at Utrecht Science Park where it met with the Amsterdam and Utrecht region.